Label: NICAZYME tablet
- NHRIC Code(s): 69336-404-30
- Packager: Sterling Knight Pharmaceuticals LLC
- Category: DIETARY SUPPLEMENT
- DEA Schedule: None
- Marketing Status: Dietary Supplement
Updated June 18, 2019
If you are a consumer or patient please visit this version.
Nicazyme is an orally administered prescription dietary supplement formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.
Nicazyme should be administered under the supervision of a licensed medical practitioner.
INDICATIONS AND USAGE:
Nicazyme is indicated for patients who are deficient in, or at risk of deficiency, in, one or more of the components of the product.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Nicazyme should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.
WARNINGS AND PRECAUTIONS:
This product should be administered with caution in patients with a history of liver disease, jaundice or diabetes mellitus.
Folic acid above 1mg daily may obscure pernicious anemia in that hematologic remission may occur while neurological manifestations remain progressive.
Abnormal liver function test have reported in persons takings doses of 500mg or more of naicinamide.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
- ADVERSE REACTION:
- DOSAGE AND ADMINISTRATION:
Store at controlled room temperature 15°-30°C (59°F-86°F). Keep in cool dry place. Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088. KEEP THIS OUT OF THE REACH OF CHILDREN.
Nicazyme is supplied a beige tablet dispensed in white HDPE plastic bottles of 30ct.
PRINCIPAL DISPLAY PANEL
Reserved for Professional Recommendation
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.
Sterling-Knight Pharmaceuticals, LLC
Ripley, MS 38663
INGREDIENTS AND APPEARANCE
Product Information Product Type DIETARY SUPPLEMENT Item Code (Source) NHRIC:69336-404 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NIACIN (UNII: 2679MF687A) (NIACIN - UNII:2679MF687A) NIACIN 250 mg FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID 0.5 mg PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE 4.5 mg COPPER (UNII: 789U1901C5) (COPPER - UNII:789U1901C5) COPPER 1.4 mg ZINC (UNII: J41CSQ7QDS) (ZINC - UNII:J41CSQ7QDS) ZINC 9 mg Inactive Ingredients Ingredient Name Strength MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) STEARIC ACID (UNII: 4ELV7Z65AP) MAGNESIUM STEARATE (UNII: 70097M6I30) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NHRIC:69336-404-30 30 in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date dietary supplement 06/05/2019 Supplement Facts Serving Size : Serving per Container : Amount Per Serving % Daily Value color shape size (solid drugs) 22 mm scoring 1 Labeler - Sterling Knight Pharmaceuticals LLC (079556942)